Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

86 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Reliability, Validity, and Feasibility of a Computer-Based Geriatric Assessment for Older Adults With Cancer.
Hurria A, Akiba C, Kim J, Mitani D, Loscalzo M, Katheria V, Koczywas M, Pal S, Chung V, Forman S, Nathwani N, Fakih M, Karanes C, Lim D, Popplewell L, Cohen H, Canin B, Cella D, Ferrell B, Goldstein L. Hurria A, et al. Among authors: nathwani n. J Oncol Pract. 2016 Dec;12(12):e1025-e1034. doi: 10.1200/JOP.2016.013136. Epub 2016 Sep 30. J Oncol Pract. 2016. PMID: 27624950 Free PMC article. Clinical Trial.
A phase II study of vorinostat and rituximab for treatment of newly diagnosed and relapsed/refractory indolent non-Hodgkin lymphoma.
Chen R, Frankel P, Popplewell L, Siddiqi T, Ruel N, Rotter A, Thomas SH, Mott M, Nathwani N, Htut M, Nademanee A, Forman SJ, Kirschbaum M. Chen R, et al. Among authors: nathwani n. Haematologica. 2015 Mar;100(3):357-62. doi: 10.3324/haematol.2014.117473. Epub 2015 Jan 16. Haematologica. 2015. PMID: 25596263 Free PMC article. Clinical Trial.
Melphalan-Based Reduced-Intensity Conditioning is Associated with Favorable Disease Control and Acceptable Toxicities in Patients Older Than 70 with Hematologic Malignancies Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.
Al Malki MM, Nathwani N, Yang D, Armenian S, Dadwal S, Salman J, Mokhtari S, Cao T, Sandhu K, Rouse M, Mei M, Ali H, Parker P, Alvarnas J, Smith E, Donnell MO, Marcucci G, Snyder D, Nademanee A, Forman SJ, Stein A, Nakamura R. Al Malki MM, et al. Among authors: nathwani n. Biol Blood Marrow Transplant. 2018 Sep;24(9):1828-1835. doi: 10.1016/j.bbmt.2018.04.029. Epub 2018 May 9. Biol Blood Marrow Transplant. 2018. PMID: 29753158 Free PMC article.
Understanding Caregiver Quality of Life in Caregivers of Hospitalized Older Adults With Cancer.
Hsu T, Nathwani N, Loscalzo M, Chung V, Chao J, Karanes C, Koczywas M, Forman S, Lim D, Siddiqi T, Stein A, Twardowski P, Nademanee A, Pal S, Siccion E, Hein M, Akiba C, Goldstein L, Smith D, Ma H, Feng T, Hurria A. Hsu T, et al. Among authors: nathwani n. J Am Geriatr Soc. 2019 May;67(5):978-986. doi: 10.1111/jgs.15841. Epub 2019 Mar 22. J Am Geriatr Soc. 2019. PMID: 30901083
Phase I/II trial of the oral regimen ixazomib, pomalidomide, and dexamethasone in relapsed/refractory multiple myeloma.
Krishnan A, Kapoor P, Palmer JM, Tsai NC, Kumar S, Lonial S, Htut M, Karanes C, Nathwani N, Rosenzweig M, Sahebi F, Somlo G, Duarte L, Sanchez JF, Auclair D, Forman SJ, Berdeja JG. Krishnan A, et al. Among authors: nathwani n. Leukemia. 2018 Jul;32(7):1567-1574. doi: 10.1038/s41375-018-0038-8. Epub 2018 Feb 23. Leukemia. 2018. PMID: 32082000 Free PMC article.
Repurposing leflunomide for relapsed/refractory multiple myeloma: a phase 1 study.
Rosenzweig M, Palmer J, Tsai NC, Synold T, Wu X, Tao S, Hammond SN, Buettner R, Duarte L, Htut M, Karanes C, Nathwani N, Pichiorri F, Sahebi F, Sanchez JF, Chowdhury A, Krishnan A, Forman SJ, Rosen ST. Rosenzweig M, et al. Among authors: nathwani n. Leuk Lymphoma. 2020 Jul;61(7):1669-1677. doi: 10.1080/10428194.2020.1742900. Epub 2020 Apr 8. Leuk Lymphoma. 2020. PMID: 32268821 Free PMC article. Clinical Trial.
Toxicities Associated With Metformin/Ritonavir Combination Treatment in Relapsed/Refractory Multiple Myeloma.
Nathwani N, Palmer J, Synold TW, Salehian B, Rosenzweig M, Sanchez JF, Hammond SN, Adekola K, Tomarchio V, Chowdhury A, Karanes C, Htut M, Sahebi F, Siddiqi T, Krishnan A, Forman SJ, Rosen ST. Nathwani N, et al. Clin Lymphoma Myeloma Leuk. 2020 Oct;20(10):e667-e672. doi: 10.1016/j.clml.2020.05.017. Epub 2020 May 29. Clin Lymphoma Myeloma Leuk. 2020. PMID: 32631779 Free PMC article. No abstract available.
Identifying CD38+ cells in patients with multiple myeloma: first-in-human imaging using copper-64-labeled daratumumab.
Krishnan A, Adhikarla V, Poku EK, Palmer J, Chaudhry A, Biglang-Awa VE, Bowles N, Nathwani N, Rosenzweig M, Sahebi F, Karanes C, Simpson J, Sanchez JF, Yamauchi D, Parayno M, Chowdhury A, Caserta E, Marcucci G, Rockne R, Wu AM, Wong J, Forman SJ, Colcher D, Yazaki P, Shively J, Pichiorri F. Krishnan A, et al. Among authors: nathwani n. Blood Adv. 2020 Oct 27;4(20):5194-5202. doi: 10.1182/bloodadvances.2020002603. Blood Adv. 2020. PMID: 33095874 Free PMC article. Clinical Trial.
86 results